[Form 4] Bloomin' Brands, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Bloomin' Brands, Inc. (BLMN) reported an insider grant: Chief Human Resources Officer Jessica L. Mitory was awarded restricted stock units (RSUs) on September 2, 2025. Two RSU grants were reported: 100,000 RSUs and 29,091 RSUs, which together represent 129,091 contingent shares that convert to common stock upon vesting. Each RSU equals one share on vesting and both grants vest in three equal annual installments with final vesting in 2028.

The grants were reported on Form 4 filed by a single reporting person and executed under attorney-in-fact signature. The RSUs were granted at $0 exercise/conversion price, consistent with typical restricted stock unit awards rather than option purchases. The filing shows these awards as directly beneficially owned following the grant.

Positive

• Material grant disclosed for transparency: 100,000 RSUs and 29,091 RSUs reported on Form 4
• Vesting schedule provided: both grants vest in three equal annual installments with final vesting in 2028
• RSUs convert 1:1 to common stock on vesting, clarifying economic entitlement

Negative

• No disclosure of prior holdings or total outstanding shares, limiting assessment of dilution
• No detail on performance conditions; filing does not state whether awards are time-based or performance-based
• Grant valuation not provided (reported price $0), so monetary impact is not directly quantifiable from this filing

Insights

Corporate Governance Expert

TL;DR: Executive equity awards align pay with shareholder outcomes but warrant disclosure of total existing holdings for context.

The reported RSU grants of 129,091 shares to the CHRO are a standard long-term compensation tool tying retention and performance to share price. Vesting over three annual installments through 2028 encourages multi-year retention. Reporting as direct beneficial ownership and a Form 4 filing meet disclosure norms. The filing does not disclose whether awards are performance-based or time-based beyond vesting schedule, nor does it state prior holdings, which limits assessment of dilution and incentive alignment.

Compensation Analyst

TL;DR: Materiality is modest; the award size appears significant in isolation but lacks context on total outstanding shares or executive pay package.

The grants are listed at a $0 conversion price, typical for RSUs that convert to common stock on vesting. The total of 129,091 RSUs vests in three equal installments, implying approximately 43,030 RSUs vest per year for each grant tranche. Without disclosure of target performance conditions, grant-date valuation, or the issuer's share count, it is not possible to quantify dilution or percent-of-pay metrics. As reported, the transaction is routine compensation disclosure rather than a market-moving event.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mitory Jessica L

(Last) (First) (Middle)

2202 N. WEST SHORE BLVD.

SUITE 500

(Street)

TAMPA FL 33607

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bloomin' Brands, Inc. [ BLMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
No securities beneficially owned.								0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	09/02/2025		A		100,000		(2)	(3)	Common Stock	100,000	$0	100,000	D
Restricted Stock Units	$0(1)	09/02/2025		A		29,091		(4)	(3)	Common Stock	29,091	$0	29,091	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock of the issuer upon vesting of the unit.

2. On September 2, 2025, these RSUs were granted in the original amount of 100,000, which vest in three equal annual installments, with a final vesting in 2028.

3. This field is not applicable.

4. On September 2, 2025, these RSUs were granted in the original amount of 29,091, which vest in three equal annual installments, with a final vesting in 2028.

Remarks:

	/s/ Allison Hicks, Attorney in Fact	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Jessica L. Mitory report on Form 4 for BLMN?

The filing reports grants of 100,000 RSUs and 29,091 RSUs on September 2, 2025, which vest in three equal annual installments with final vesting in 2028.

How many total restricted stock units were granted to the CHRO?

A total of 129,091 RSUs were granted (100,000 plus 29,091).

What is the conversion price or cost for these RSUs?

The RSUs are reported with a $0 conversion/exercise price, which is standard for restricted stock units that convert to shares on vesting.

When will the RSUs vest?

Both grants vest in three equal annual installments, with the final vesting occurring in 2028.

Was the Form 4 filed by one reporting person or multiple?

The Form 4 was filed by one reporting person.